市场调查报告书
商品编码
1597098
欧洲色素沉着过度障碍治疗市场预测至 2030 年 - 区域分析 - 按治疗类型、病情和最终用户Europe Hyperpigmentation Disorder Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type, Condition, and End User |
2022年欧洲色素沉着过度障碍治疗市场价值为110099万美元,预计2030年将达到191195万美元;预计2022年至2030年复合年增长率为7.1%。
越来越多的色素沉着过度疾病意识计画推动了欧洲色素沉着过度疾病治疗市场
提高人们对紫外线引起的皮肤色素沉着过度认识的运动对于教育广大民众预防、筛检、诊断和治疗这些疾病至关重要;他们也讨论了使用优质防晒产品来控制这些疾病的重要性。
2022 年 5 月 25 日,贝拉·奥罗拉 (Bella Aurora) 庆祝了国际皮肤色素沉着日。贝拉·奥罗拉(Bella Aurora)在皮肤色素沉着研究方面拥有130 多年的经验,在西班牙和义大利着名皮肤科医生、药剂师和关键意见领袖的支持下,发起了一项国际宣传活动来庆祝这一天。 2021 年 6 月,Dermalogica Clear 发起了一项活动,鼓励皮肤接受并教育受众有关发炎后色素沉着、痤疮、痘痘等问题。
人们对黄褐斑和其他色素沉着过度疾病的认识不断提高,导致对创新有效的治疗产品和程序的需求激增。此外,它还为社会理解和管理色素沉着的方式带来了重大而积极的变化。因此,越来越多的意识计划促进了色素沉着过度疾病治疗市场的成长。
欧洲色素沉着过度疾病治疗市场概述
欧洲色素沉着过度障碍治疗市场分为德国、英国、法国、义大利、西班牙和欧洲其他国家。 2023 年,德国占据欧洲最大的色素沉着过度障碍治疗市场份额。德国人越来越积极地寻求先进的护肤解决方案,以解决黄褐斑、老年斑和发炎后色素沉着等色素沉着过度疾病,从而推动了市场对创新疗法的需求。此外,德国人口老化的加剧导致了许多与年龄相关的皮肤问题,包括色素沉着过度,促使人们寻求专门的治疗来保持皮肤容光焕发。据德国联邦统计局(Statistisches Bundesamt)称,到2030年代中期,67岁及以上的人口数量将从400万增加到至少2000万。德国重视皮肤护理和抗衰老解决方案的文化,加上人口老化和皮肤病高发生率,增加了对色素沉着过度疾病治疗的需求。此外,人们对外表的日益关注和担忧仍然是增加各种整容手术需求的关键因素,从而促进了市场的强劲成长。此外,德国拥有先进的医疗基础设施、熟练的皮肤科医生和信誉良好的美容诊所,有助于获得广泛的色素沉着过度治疗和手术,吸引了寻求优质皮肤护理服务的国内外患者。
欧洲色素沉着过度疾病治疗市场收入及 2030 年预测(百万美元)
欧洲色素沉着过度疾病治疗市场细分
欧洲色素沉着过度障碍治疗市场按治疗类型、病情、最终用户和国家分类。
根据治疗类型,欧洲色素沉着过度障碍治疗市场分为药妆、光或雷射疗法、微晶磨皮、化学换肤、冷冻疗法等。 2022年,药妆领域占据最大的市场份额。
根据病情,欧洲色素沉着过度障碍治疗市场分为黄褐斑、日光性雀斑、发炎后色素沉着等。黄褐斑细分市场在 2022 年占据最大的市场。
根据最终用户,欧洲色素沉着过度障碍治疗市场分为医院、皮肤科中心等。 2022 年,医院细分市场占据最大的市场份额。
依国家/地区划分,欧洲色素沉着过度障碍治疗市场分为德国、英国、法国、义大利、西班牙和欧洲其他国家。 2022 年,德国在欧洲色素沉着过度障碍治疗市场份额中占据主导地位。
艾伯维公司、拜耳公司、EpiPharm AG、Galderma SA、欧莱雅 SA、Lutronic Co Ltd、Obagi Cosmeceuticals LLC 和 Pierre Fabre SA 是欧洲色素沉着过度障碍治疗市场的一些领先公司。
The Europe hyperpigmentation disorder treatment market was valued at US$ 1,100.99 million in 2022 and is expected to reach US$ 1,911.95 million by 2030; it is estimated to register a CAGR of 7.1% from 2022 to 2030.
Increasing Number of Hyperpigmentation Disorder Awareness Programs Drives Europe Hyperpigmentation Disorder Treatment Market
Campaigns to raise awareness about UV-induced skin hyperpigmentation are essential to educate the general populace on the prevention, screening, diagnosis, and treatment of these conditions; they also discuss the importance of using good-quality sunscreen products to manage these disorders.
On May 25, 2022, Bella Aurora celebrated the International Skin Pigmentation Day. With over 130 years of experience in the research of skin pigmentation, Bella Aurora launched an international awareness campaign to celebrate the day with the support of renowned dermatologists, pharmacists, and key opinion leaders across the Spain and Italy. In June 2021, Dermalogica Clear launched a campaign to encourage skin acceptance and educate audiences on post-inflammatory hyperpigmentation, acne, breakouts, and more.
The increased awareness of melasma and other hyperpigmentation disorders has led to a surge in demand for innovative and efficacious treatment products and procedures. Moreover, it has brought about a significant and positive change in how society understands and manages hyperpigmentation. Thus, the increasing number of awareness programs bolsters the growth of the hyperpigmentation disorder treatment market.
Europe Hyperpigmentation Disorder Treatment Market Overview
The hyperpigmentation disorder treatment market in Europe is segmented into Germany, UK, France, Italy, Spain, and Rest of Europe. The Germany held the largest Europe hyperpigmentation disorder treatment market share in 2023. Factors such as increasing awareness and emphasis on skincare and dermatological health among the population driving the market growth. Germans are increasingly proactive in seeking advanced skincare solutions to address hyperpigmentation disorders such as melasma, age spots, and post-inflammatory hyperpigmentation, driving the demand for innovative treatments in the market. Additionally, the rise in the aging population in Germany has led to numerous age-related skin concerns, including hyperpigmentation, prompting individuals to seek specialized treatments to maintain radiant skin. According to the Federal Statistical Office of Germany (Statistisches Bundesamt), the number of people aged 67 and above would increase from 4 million to at least 20 million by the mid-2030s. A culture that values skin care and anti-aging solutions, coupled with population aging and high skin disease prevalence, contributes to the demand for hyperpigmentation disorder treatments in Germany. Furthermore, rising attention and concerns about appearance continue to be a key factor in increasing the demand for various cosmetic procedures, contributing to strong market growth. Moreover, the presence of advanced medical infrastructure, skilled dermatologists, and reputable cosmetic clinics in Germany contributes to the accessibility of a wide range of hyperpigmentation treatments and procedures, attracting both domestic and international patients seeking quality skin care services.
Europe Hyperpigmentation Disorder Treatment Market Revenue and Forecast to 2030 (US$ Million)
Europe Hyperpigmentation Disorder Treatment Market Segmentation
The Europe hyperpigmentation disorder treatment market is categorized into treatment type, condition, end user, and country.
Based on treatment type, the Europe hyperpigmentation disorder treatment market is segmented into cosmeceutical, light or laser therapy, microdermabrasion, chemical peels, cryotherapy, and others. The cosmeceutical segment held the largest market share in 2022.
Based on condition, the Europe hyperpigmentation disorder treatment market is segmented into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. The melasma segment held the largest market share in 2022.
Based on end user, the Europe hyperpigmentation disorder treatment market is segmented into hospitals, dermatology centers, and others. The hospitals segment held the largest market share in 2022.
By country, the Europe hyperpigmentation disorder treatment market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe hyperpigmentation disorder treatment market share in 2022.
AbbVie Inc, Bayer AG, EpiPharm AG, Galderma SA, L'OREAL S.A., Lutronic Co Ltd, Obagi Cosmeceuticals LLC, and Pierre Fabre SA are some of the leading companies operating in the Europe hyperpigmentation disorder treatment market.